最新消息

News & Message

:::
首頁/
最新消息/
期刊論文/
 Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion

最新消息

2025/7/31

 Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion

Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion
作者群：Dongli Linghu, Jiaming Song, Liyan Gu, Chengjie Liu, Boning Liu, Riyao Yang, Qihui Chen, Jun Yao, Swathi Priya Manickam, Navaneethan Sundhar, 涂智彥(Chih-Yen Tu), 陳家弘(Chia-Hung Chen), Zhiguo Liu, Delong Liu, Hsiao-Fan Chen 6 8, Shasha Shi, Shunjie Xiong, 洪明奇(Mien-Chie Hung), Linlin Sun
期刊：The Journal for ImmunoTherapy of Cancer
出版年月：2025 Jul.
https://pubmed.ncbi.nlm.nih.gov/40664443/

回上頁

相關文章

 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration
 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration
 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens
 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens
 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial
 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂
分享到： 文心一言 百度知道 支付宝 微博 QQ空间 QQ 豆瓣 知乎 CSDN 博客园 简书 百家号 搜狐号 网易号 腾讯
百度 搜狗 360搜索 八零娇女一撒娇,高冷军少领证了 秘密总部 霸道龙尊 六姊妹 触碰蔷薇 
      <code id='429b7'></code><style id='4d8f6'></style>
      • <acronym id='2c7e7'></acronym>
      <center id='40799'><center id='b9eeb'><tfoot id='4032e'></tfoot></center><abbr id='ea475'><dir id='d86f2'><tfoot id='4a921'></tfoot><noframes id='d0cf3'>
      • <optgroup id='65366'><strike id='1e0b9'><sup id='a8c7e'></sup></strike><code id='b7cba'></code></optgroup>
        5. <b id='38acb'><label id='fe578'><select id='b2de2'><dt id='66c4e'><span id='e904b'></span></dt></select></label></b><u id='de242'></u>
          <i id='35ce4'><strike id='c1502'><tt id='391c0'><pre id='44d9d'></pre></tt></strike></i>